Explore the words cloud of the CISTEM project. It provides you a very rough idea of what is the project "CISTEM" about.
The following table provides information about the project.
Coordinator |
BIOSENSE INSTITUTE - RESEARCH AND DEVELOPMENT INSTITUTE FOR INFORMATION TECHNOLOGIES IN BIOSYSTEMS
Organization address contact info |
Coordinator Country | Serbia [RS] |
Total cost | 364˙500 € |
EC max contribution | 364˙500 € (100%) |
Programme |
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) |
Code Call | H2020-MSCA-RISE-2017 |
Funding Scheme | MSCA-RISE |
Starting year | 2018 |
Duration (year-month-day) | from 2018-01-01 to 2021-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | BIOSENSE INSTITUTE - RESEARCH AND DEVELOPMENT INSTITUTE FOR INFORMATION TECHNOLOGIES IN BIOSYSTEMS | RS (NOVI SAD) | coordinator | 198˙000.00 |
2 | UNIVERSIDAD DE ZARAGOZA | ES (ZARAGOZA) | participant | 67˙500.00 |
3 | UNIWERSYTET JAGIELLONSKI | PL (KRAKOW) | participant | 40˙500.00 |
4 | BEONCHIP SL | ES (ZARAGOZA) | participant | 27˙000.00 |
5 | ELVESYS | FR (PARIS) | participant | 18˙000.00 |
6 | CHERRY BIOTECH | FR (RENNES) | participant | 13˙500.00 |
7 | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | US (NEW BRUNSWICK) | partner | 0.00 |
8 | UNIVERSIDAD DE BUENOS AIRES | AR (BUENOS AIRES) | partner | 0.00 |
Many rare diseases cause chronic health problems or are even life-threatening. The impact on the quality of life of affected patients, of whom many are children, is significant. To date, a limited but increasing number of so-called orphan drugs (drugs for rare diseases) are reaching patients. However, the majority of rare diseases are still without any effective treatment. The development of novel human systems for drug discovery therefore represents a major public health priority. Microfluidic technology-based “Organs-on-a-chip” represents a powerful tool for investigating rare disease mechanisms and testing new drug and treatment due to their ability to mimic tailored micro-environment architecture inspired by organ-level functions in vivo. However, due to the variability in rare disease mechanisms from one patient to another, organ on chip technology needs to be more precise and to convey towards personalized medicine. The human-induced pluripotent stem cells (iPSCs) have a strong potential in engineering organ-on-a-chip since they are derived in a patient-matched manner which makes them a superb source to construct human models for personalized drug screening as well as for understanding patient-specific fundamentals of diseases. To provide novel miniaturized platform for investigation of rare diseases able to address the burning issues in precision medicine today, CISTEM will bring together and synergistically several highly promising research directions which are too often investigated separately at the academic level but also at the industrial level. Based on 4 work packages, the CISTEM RISE project will be implemented by exploiting the complementary expertise of its partners and creating synergies between them through the targeted secondments of staff.
Communication and public engagement plan No. 1 | Documents, reports | 2020-02-18 11:09:43 |
Project website | Websites, patent fillings, videos etc. | 2020-02-18 11:09:43 |
Take a look to the deliverables list in detail: detailed list of CISTEM deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CISTEM" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CISTEM" are provided by the European Opendata Portal: CORDIS opendata.
RELIABLE TECHNOLOGIES AND MODELS FOR VERIFIED WIRELESS BODY-CENTRIC TRANSMISSION AND LOCALIZATION
Read MoreOutcomes of Patients’ Evidence With Novel, Do-It-Yourself Artificial Pancreas Technology
Read MoreIdentifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategy
Read More